Handel nachbörslich: 104.96

Blueprint Medicines Corp (BPMC)

Blueprint Medicines Corp Aktie (BPMC) Neueste Nachrichten

Blueprint Medicines Corp (BPMC)

Blueprint Medicines Corp Aktie (BPMC) Neueste Nachrichten

Amalgamated Bank Cuts Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Blueprint Medicines Co. (NASDAQ:BPMC) Short Interest Update - MarketBeat

Blueprint Medicines Co. (NASDAQ:BPMC) to Post Q2 2024 Earnings of ($1.40) Per Share, Zacks Research Forecasts - MarketBeat

Is Blueprint Medicines Corp (BPMC) positioned for future growth? – Sete News - SETE News

Blueprint Medicines Corp [BPMC] Insider Activity: An Update for Investors – Knox Daily - Knox Daily

Blueprint Medicines Corp (BPMC) presents a great opportunity, but the stock is slightly undervalued – US Post News - US Post News

Blueprint Medicines (NASDAQ:BPMC) Research Coverage Started at Stephens - MarketBeat

Blueprint Medicines (NASDAQ:BPMC) Sets New 52-Week High at $111.02 - MarketBeat

Unveiling 18 Analyst Insights On Blueprint Medicines - Blueprint Medicines (NASDAQ:BPMC) - Benzinga

Stephens calls Blueprint Medicines its 'best idea', rates stock overweight - Investing.com South Africa

Stephens calls Blueprint Medicines its 'best idea', rates stock overweight - Investing.com

Stephens calls Blueprint Medicines its 'best idea', rates stock overweight - Investing.com India

Van ECK Associates Corp Acquires 193 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Swiss National Bank Sells 19,400 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) - MarketBeat

Swiss National Bank Sells 19400 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) - Defense World

Blueprint Medicines Co. (NASDAQ:BPMC) Shares Sold by Russell Investments Group Ltd. - Defense World

Blueprint Medicines Co. to Post Q2 2024 Earnings of ($1.10) Per Share, Leerink Partnrs Forecasts (NASDAQ:BPMC) - MarketBeat

Blueprint Medicines (BPMC) Files Ayvakit sNDA for Indolent SM - Yahoo New Zealand News

Blueprint Medicines Co. Forecasted to Earn FY2027 Earnings of $5.34 Per Share (NASDAQ:BPMC) - Defense World

Blueprint Medicines (NASDAQ:BPMC) Upgraded by Leerink Partnrs to Market Perform - Defense World

Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand - Yahoo Finance

Blueprint Medicines Co. (NASDAQ:BPMC) Insider Ariel Hurley Sells 1,834 Shares - MarketBeat

Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand - Yahoo Finance

Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – Company Announcement ... - Financial Times

PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?

An analyst sees good growth prospects for Blueprint Medicines Corp (BPMC) – Sete News - SETE News

5 Biotech Stocks Worth Adding to Your Portfolio in 2024

StockNews.com Upgrades Blueprint Medicines (NASDAQ:BPMC) to “Hold” - Defense World

Barclays Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $75.00 - Defense World

Blueprint Medicines (NASDAQ:BPMC) PT Raised to $135.00 at HC Wainwright - Defense World

Blueprint Medicines (NASDAQ:BPMC) Receives Buy Rating from Needham & Company LLC - Defense World

Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

Blueprint Medicines (NASDAQ:BPMC) Raised to Hold at StockNews.com - MarketBeat

Blueprint Medicines: Q1 Earnings Snapshot - Milford Mirror

Earnings call: Blueprint Medicines raises AYVAKIT guidance amid growth - Investing.com

Blueprint Medicines Corp: Navigating Market Fluctuations with a 6.49B Market Cap – Invest Chronicle - The InvestChronicle

Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates

Blueprint Medicines (NASDAQ:BPMC) Rating Reiterated by Needham & Company LLC - MarketBeat

Strength in Kidney Care Likely to Aid DaVita's (DVA) Q1 Earnings

Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?

What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?

Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know

Blueprint Medicines Co. (NASDAQ:BPMC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Jackson Creek Investment Advisors LLC Makes New $1.43 Million Investment in Blueprint Medicines Co. (NASDAQ ... - MarketBeat

Sustained Product Demand Likely to Aid BD's (BDX) Q2 Earnings

Factors Setting the Tone for Ecolab's (ECL) Q1 Earnings

The Analyst Verdict: Blueprint Medicines In The Eyes Of 7 Experts

The Analyst Verdict: Blueprint Medicines In The Eyes Of 7 Experts - Blueprint Medicines (NASDAQ:BPMC) - Benzinga

Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Ähnlich wie BPMC